In vitro host range, multiplication and virion forms of recombinant viruses obtained from co-infection in vitro with a vaccinia-vectored influenza vaccine and a naturally occurring cowpox virus isolate
Open Access
- 13 May 2009
- journal article
- Published by Springer Nature in Virology Journal
- Vol. 6 (1) , 55
Abstract
Poxvirus-vectored vaccines against infectious diseases and cancer are currently under development. We hypothesized that the extensive use of poxvirus-vectored vaccine in future might result in co-infection and recombination between the vaccine virus and naturally occurring poxviruses, resulting in hybrid viruses with unpredictable characteristics. Previously, we confirmed that co-infecting in vitro a Modified vaccinia virus Ankara (MVA) strain engineered to express influenza virus haemagglutinin (HA) and nucleoprotein (NP) genes with a naturally occurring cowpox virus (CPXV-NOH1) resulted in recombinant progeny viruses (H Hansen, MI Okeke, Ø Nilssen, T Traavik, Vaccine 23: 499–506, 2004). In this study we analyzed the biological properties of parental and progeny hybrid viruses.Keywords
This publication has 66 references indexed in Scilit:
- Survival of lethal poxvirus infection in mice depends on TLR9, and therapeutic vaccination provides protectionJournal of Clinical Investigation, 2008
- Enhanced cell surface expression, immunogenicity and genetic stability resulting from a spontaneous truncation of HIV Env expressed by a recombinant MVAVirology, 2008
- Poxviruses: past, present and futureVirus Research, 2006
- Modified vaccinia virus Ankara multiplies in rat IEC-6 cells and limited production of mature virions occurs in other mammalian cell linesJournal of General Virology, 2006
- Recombinant modified vaccinia Ankara primes functionally activated CTL specific for a melanoma tumor antigen epitope in melanoma patients with a high risk of disease recurrenceInternational Journal of Cancer, 2004
- Lack of Vaccinia Viremia after Smallpox VaccinationClinical Infectious Diseases, 2004
- Tissue distribution of the Ankara strain of vaccinia virus (MVA) after mucosal or systemic administrationArchives of Virology, 2003
- Identification of the Orthopoxvirus p4c Gene, Which Encodes a Structural Protein That Directs Intracellular Mature Virus Particles into A-Type InclusionsJournal of Virology, 2002
- Vaccinia Virus DNA Polymerase Promotes DNA Pairing and Strand-Transfer ReactionsVirology, 1999
- Intragenic and intergenic recombination between temperature-sensitive mutants of vaccinia virusJournal of General Virology, 1991